The Pandemic Respiratory Virus Epidemiological Surveillance Trial - A Self-swab Surveillance System for Respiratory Viruses Nested Within FluTracking - Scorecard - MDSpire
Advertisement
The Pandemic Respiratory Virus Epidemiological Surveillance Trial - A Self-swab Surveillance System for Respiratory Viruses Nested Within FluTracking
Clinical Scorecard: Epidemiological Monitoring of Respiratory Viruses: A Self-Sampling Surveillance Approach Integrated with FluTracking
At a Glance
Category
Detail
Condition
Respiratory virus infections including symptomatic and asymptomatic cases
Key Mechanisms
Weekly self-collected nasal swabs tested by multiplex PCR combined with symptom surveys
Target Population
Community-dwelling adults enrolled in FluTracking in Newcastle, Australia
Care Setting
Community-based surveillance with postal sample return
Key Highlights
Self-collected nasal swabs returned by mail are feasible and maintain viral genome stability for at least 7 days.
11% of participant-weeks had at least one respiratory virus detected; 24.2% of detections were asymptomatic.
Rhinovirus and SARS-CoV-2 were the most frequently detected viruses in community samples.
Guideline-Based Recommendations
Diagnosis
Use unsupervised self-collected nasal swabs for respiratory virus detection in community surveillance.
Employ multiplex PCR panels to identify a broad range of respiratory viruses from nasal swabs.
Management
Integrate symptom surveys with virological testing to capture both symptomatic and asymptomatic infections.
Encourage weekly sampling irrespective of symptom status to better understand transmission dynamics.
Monitoring & Follow-up
Maintain longitudinal data collection from the same participants to track virus circulation over time.
Ensure timely sample return and proper storage (4°C) to preserve sample integrity.
Risks
Discard samples with delayed postage or leakage to avoid compromised results.
Consider asymptomatic viral shedding in transmission risk assessments.
Patient & Prescribing Data
Community-dwelling adults participating in FluTracking with high survey response rates
Regular self-sampling combined with symptom tracking provides valuable epidemiological data but does not directly inform individual treatment decisions.
Clinical Best Practices
Recruit participants with established engagement in symptom surveillance platforms to ensure compliance.
Provide clear instructions and materials for self-collection and postal return of nasal swabs.
Schedule periodic distribution of collection materials to participants to support continuous sampling.
Instruct participants to refrigerate samples if immediate postage is not possible to maintain sample quality.
by Camille Esneau, David Boettiger, Sarah Leask, Nathan E Bryant, Natalie Niessen, Jodie McVernon, Adrian Marcato, Sandra Carlson, Stuart Browne, Rejoy Thomas, Edward C Holmes, Krispin Hajkowicz, Lynelle Tilbrook, Nathan Moon, Craig Dalton, Nathan W Bartlett, Joshua S Davis
